Evidence map›Paper›PMID 37075074›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Rapid cancer cell perineural invasion utilizes amoeboid migration.

Andrea R Marcadis, Elizabeth Kao, Qi Wang, Chun-Hao Chen, Laxmi Gusain, Ann Powers, Richard L Bakst, Sylvie Deborde, Richard J Wong

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Amoeboid-mesenchymal transition and the proteolytic control of cancer invasion plasticity.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Capped high-force integrin bond lifetimes and spacing-tuned binding frequency drive rapid fibroblast migration.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Andrea R MarcadisDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065.ORCID 0000-0001-8439-5705
Elizabeth KaoDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065.ORCID 0000-0001-9738-0676
Qi WangDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065.ORCID 0000-0002-4242-6996
Chun-Hao ChenDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065.ORCID 0000-0003-4785-5201
Laxmi GusainDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065.ORCID 0000-0002-7140-5350
Ann PowersDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
Richard L BakstDepartment of Radiation Oncology, Mount Sinai Medical Center, New York, NY 10029.ORCID 0000-0001-9279-7878
Sylvie DebordeDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065.ORCID 0000-0002-6630-4029
Richard J WongDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065.ORCID 0000-0001-6259-7314
Memorial Sloan Kettering Cancer Center · USMount Sinai Medical Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
HEAD AND NECK TRAINING PROGRAM SURGICAL ONCOLOGYT32CA009685 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI FAGIN, JAMES A, WONG, RICHARD J · 1992 to 2022
$3.6M
Schwann Cell Reprogramming and Cancer Perineural InvasionR01CA219534 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI WONG, RICHARD J · 2017 to 2021
$3.1M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA219534NCI NIH HHS T32 CA009685
6 · The paper itself

Abstract

The invasion of nerves by cancer cells, or perineural invasion (PNI), is potentiated by the nerve microenvironment and is associated with adverse clinical outcomes. However, the cancer cell characteristics that enable PNI are poorly defined. Here, we generated cell lines enriched for a rapid neuroinvasive phenotype by serially passaging pancreatic cancer cells in a murine sciatic nerve model of PNI. Cancer cells isolated from the leading edge of nerve invasion showed a progressively increasing nerve invasion velocity with higher passage number. Transcriptome analysis revealed an upregulation of proteins involving the plasma membrane, cell leading edge, and cell movement in the leading neuroinvasive cells. Leading cells progressively became round and blebbed, lost focal adhesions and filipodia, and transitioned from a mesenchymal to amoeboid phenotype. Leading cells acquired an increased ability to migrate through microchannel constrictions and associated more with dorsal root ganglia than nonleading cells. ROCK inhibition reverted leading cells from an amoeboid to mesenchymal phenotype, reduced migration through microchannel constrictions, reduced neurite association, and reduced PNI in a murine sciatic nerve model. Cancer cells with rapid PNI exhibit an amoeboid phenotype, highlighting the plasticity of cancer migration mode in enabling rapid nerve invasion.

Indexed as

AmoebaNerve TissuePancreatic NeoplasmsAnimalsCell MovementMiceNeoplasm InvasivenessPancreasSciatic NerveTumor Microenvironmentamoeboidinvasionmigrationperineural

Identifiers

PMID37075074
PMCPMC10151474
OpenAlexW4366352686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.